Anti-HER2 treatment in everyday practice: how we treat older women with breast cancer differently
{{output}}
Purpose: Targeted therapies have improved survival in human epidermal growth factor receptor 2 positive breast cancer (HER2 + BC). However, patients over 75 years of age are often excluded from clinical trials of anti-HER2 therap... ...
